Are all fish oil supplements safe during pregnancy? by Opperman, Maretha & Benade, Spinnler
CORRESPONDENCE
389       June 2014, Vol. 104, No. 6
Are all fish oil supplements safe 
during pregnancy?
To the Editor: Few consumers are aware of the ethyl ester (EE) 
content of South African (SA) omega-3 fatty acid supplements.
We wish to draw the attention of SAMJ readers to the findings of 
a recent survey on the omega-3 fatty acid content of fish oil supple-
ments available on the SA market. This survey revealed that 20 of the 
63 supplements analysed (31.7%) contained omega-3 fatty acids in 
EE form, or a combination of EEs and triglycerides (TGs).[1] In pure 
fish oils the omega-3 fatty acids are almost exclusively in the form of 
TGs. EEs are esterified products of fatty acids and ethanol. During 
the esterification process the glycerol backbone of TGs is removed 
by substituting it with ethanol. Omega-3 EEs are then separated from 
other EEs by molecular distillation. This process enables selective 
concentration of eicosapentaenoic acid and docosahexaenoic acid, 
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in excess of levels in natural fish oil. These preparations are typically 
marketed as fish oil concentrates.
Pregnant women are advised not to use EEs, since their safety 
during pregnancy has not been established.[2] Importantly, none of 
the labels of the supplements surveyed declared the presence of EEs, 
and none of the labels warned against using EEs during pregnancy 
and lactation – there was even one supplement containing EEs that 
was specifically recommended during pregnancy. During digestion, 
EEs are converted back to TGs and ethanol is released. Even though 
the quantity of ethanol released after taking a typical dose of fish 
oil for supplementation is small, at-risk groups such as pregnant 
and lactating women, as well as young children, should avoid using 
omega-3 fatty acid supplements that contain EEs.
In some countries (although not in SA), fatty acid EEs are used 
as pre scription medications to reduce very high blood TG levels 
(≥5.65 mmol/l). However, these preparations provide pharma-
cological amounts of omega-3 fatty acid EEs and are used under 
strict supervision by a physician. It is unfortunate that the same 
procedures are not applied to ensure the safety of omega-3 fatty acid 
supplements.
We suggest that all manufacturers should indicate on the labels 
the forms in which omega-3 fatty acids are present in the fish oil/
omega-3 supplements they produce, and that the labels should also 
warn pregnant women about the use of supplements containing 
EEs. Doctors should familiarise themselves with the contents of the 
various fish oil supplements. 
This information can be accessed on the website of the Cancer 
Association of South Africa.[3] 
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